Financial Spine Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield byJosh SandbergOctober 3, 2023
Neuro Spine Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure byJosh SandbergJuly 20, 2023
Spine Relievant Medsystems Introduces Next-Generation Access Instruments to Advance Intracept Procedure for Chronic Vertebrogenic Low Back Pain byJosh SandbergJuly 14, 2023
Spine Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients byJosh SandbergJune 15, 2023
Neuro Spine Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery byChris StewartNovember 9, 2022
Spine Relievant Medsystems Announces New Category I CPT Codes for Intracept® Procedure byJosh SandbergJanuary 4, 2022
Spine Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain byJosh SandbergAugust 27, 2019
Financial Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure byChris StewartJanuary 8, 2019
Spine Phoenix Spine Announces Participation in the INTRACEPT Study for the Treatment of Chronic Low Back Pain byJosh SandbergMarch 8, 2018
